GROWTH-STIMULATION OF PRIMARY RAT HEPATOCYTES BY 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN

被引:27
|
作者
WOLFLE, D
BECKER, E
SCHMUTTE, C
机构
[1] Department of Toxicology, University of Hamburg Medical School, Hamburg 13, D-2000
关键词
DIOXIN; HEPATOCYTE GROWTH; INSULIN; TUMOR PROMOTION;
D O I
10.1007/BF00755137
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The modulation of liver growth control by the tumor promoter, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), was investigated in primary hepatocytes Of adult rats. Under defined conditions in serum-free cultures, the interaction of TCDD with growth-related hormones was studied. TCDD-treatment of the cultured hepatocytes for two days caused a transient stimulation of both DNA synthesis and mitotic activity. This effect was maximal at the very low non-toxic concentration of 10(-12) M TCDD, i.e., two orders of magnitude below the optimal concentrations for induction of drug metabolizing enzymes. Growth stimulation by TCDD was dependent on the presence of growth-related hormones; in primary rat hepatocytes, TCDD acted synergistically with insulin and epidermal growth factor (EGF) and antagonized the growth inhibition by dexamethasone. Under culture conditions allowing high rates of DNA synthesis, e.g., at low concentrations of dexamethasone, in the presence of EGF plus alpha1-adrenergic agonists or rat serum, no significant effect of TCDD on cellular growth was observed. Furthermore, TCDD failed to stimulate DNA synthesis in a rat hepatoma cell line, H4IIE, which is less sensitive to growth controlling factors than normal hepatocytes. Therefore, the results suggest that the growth modulation of primary rat hepatocytes by TCDD is the most sensitive parameter of the agent thus far observed. This effect may involve both a release from the growth inhibition caused,for instance, by glucocorticoids, as well as a direct growth-stimulating effect, synergistic to the one induced by insulin.
引用
收藏
页码:15 / 31
页数:17
相关论文
共 50 条
  • [1] 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes
    Hushka, DR
    Greenlee, WF
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 333 (1-2) : 89 - 99
  • [2] STUDY OF TERATOGENICITY OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN IN RAT
    SPARSCHU, GL
    DUNN, FL
    ROWE, VK
    FOOD AND COSMETICS TOXICOLOGY, 1971, 9 (03): : 405 - &
  • [3] TERATOGENIC STUDY OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN IN RAT
    SPARSCHU, GL
    DUNN, FL
    ROWE, VK
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1970, 17 (01) : 317 - &
  • [4] PHOTOLYSIS OF "2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN
    PLIMMER, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1974, : 29 - 29
  • [5] RADIOIMMUNOASSAY FOR "2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN
    ALBRO, PW
    CHAE, K
    LUSTER, M
    MCKINNEY, JD
    CHAUDHARY, S
    CLARK, G
    FAWKES, J
    CORBETT, J
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1977, 20 (OCT) : 247 - 247
  • [6] Cytotoxicity and mitochondrial dysfunction of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in isolated rat hepatocytes
    Aly, Hamdy A. A.
    Domenech, Oscar
    TOXICOLOGY LETTERS, 2009, 191 (01) : 79 - 87
  • [7] Hepatoprotective potential of astaxanthin against 2,3,7,8-tetrachlorodibenzo-p-dioxin in cultured rat hepatocytes
    Turkez, Hasan
    Geyikoglu, Fatime
    Yousef, Mokhtar I.
    Togar, Basak
    Gurbuz, Hasan
    Celik, Kubra
    Akbaba, Giray B.
    Polat, Zuhal
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2014, 30 (02) : 101 - 112
  • [8] 2,3,7,8-tetrachlorodibenzo-p-dioxin alters melatonin metabolism in fish hepatocytes
    Pesonen, M
    Korkalainen, M
    Laitinen, JT
    Andersson, TB
    Vakkuri, O
    CHEMICO-BIOLOGICAL INTERACTIONS, 2000, 126 (03) : 227 - 240
  • [9] 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks the physiological regulation of hepatic phosphoenolpyruvate carboxykinase activity in primary rat hepatocytes
    Stahl, BU
    TOXICOLOGY, 1995, 103 (01) : 45 - 52
  • [10] INVIVO BIOTRANSFORMATION OF "2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) IN THE RAT
    RAMSEY, JC
    HEFNER, JG
    KARBOWSKI, RJ
    BRAUN, WH
    GEHRING, PJ
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 48 (01) : A162 - A162